The efficiency of an ADC depends on multiple steps that include the successful delivery of the ADC complex to the tumor microenvironment, high-affinity binding of the antibody to the target cell surface antigen, and the rate at which it is successfully internalized and processed in the cancer cell. The gene discussed is CD53; the disease is cancer.